Cited by 143Parasitic infections in humans and animalsParasites and Host InteractionsHelminth infection and control

Human toxocariasis – A look at a neglected disease through an epidemiological ‘prism’

Open access
Rostami, Ali, Ma, Guangxu, Wang, Tao, Koehler, Anson V., Hofmann, Andreas, Chang, Bill C.H., Macpherson, Calum N., Gasser, Robin B.·2019·Infection, Genetics and Evolution

Abstract

Toxocariasis, a disease caused by infection with larvae of Toxocara canis, T. cati and/or congeners, represents clinical syndromes in humans including visceral and ocular larva migrans, neurotoxocariasis and covert/common toxocariasis. It is reported to be one of the most widespread public health and economically important zoonotic parasitic infections that humans share with dogs, wild canids, including foxes, and possibly other mammals. Humans become infected by accidental ingestion of embryonated Toxocara eggs, or larvae from tissues from domestic or wild paratenic hosts. Most infections are asymptomatic, and human disease may go unnoticed, as clinical investigation is often not pursued and/or diagnostic testing not conducted. Sometimes toxocariasis can be associated with complications, such as allergic and/or neurological disorders, possibly including cognitive or developmental delays in children. There is no anti-toxocariasis vaccine, and chemotherapy in humans varies, depending on symptoms and location of larvae, and may include the administration of albendazole or mebendazole, together with anti-inflammatory corticosteroids. Some recent studies indicate that toxocariasis is having an increased, adverse impact on human health in some, particularly underprivileged, tropical and subtropical communities around the world. Although tens of millions of people, especially children, are expected to be exposed to, or infected with Toxocara species, there is limited precise epidemiological data or information on the relationship between seropositivity and disease (toxocariasis) on a global scale. To gain an improved insight into this area, the present article reviews salient clinical aspects of human toxocariasis and the epidemiology of this disease, with particular reference to seroprevalence, and discusses future research and approaches/measures to understand and prevent/control this socioeconomically important, yet neglected zoonosis.

Integrity signals

Registry

Crossref · 10.1016/j.meegid.2019.104002

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Almost one fifth (19%; 1.4 billion individuals) of the world's human population is seropositive to Toxocara, with highest seroprevalence in Africa (mean 37.7%) and lowest in the Eastern Mediterranean region (mean 8.2%).

    “Almost one fifth (19%; 1.4 billion individuals) of the world’s human population is seropositive to Toxocara. The highest seroprevalence rates were found in Africa (mean: 37.7%) and the lowest in the Eastern Mediterranean region (mean: 8.2%) [210].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rostami, A., Ma, G., Wang, T., Koehler, A. V., Hofmann, A., Chang, B. C. H., Macpherson, C. N., & Gasser, R. B.
Affiliations
  • Babol University of Medical Sciences (IR)
  • The University of Melbourne (AU)
  • St. George's University (GD)
Corresponding author
Gasser, Robin B.
Venue
Infection, Genetics and Evolution
Publisher
Elsevier BV
Published
2019-10
Volume
74
Pages
104002
ISSN
1567-1348 (ISSN-L)
OpenAlex
W2968361216
Cited by
143
References
4
Citations by year
2026: 13 · 2025: 20 · 2024: 17 · 2023: 22 · 2022: 22 · 2021: 19 · 2020: 26 · 2019: 4
FWCI
2.64
Type
journal article
Language
en
Open access
Locations
  • Infection Genetics and Evolution (publishedVersion)
  • PubMed (publishedVersion)
  • Griffith Research Online (submittedVersion, cc-by-nc-nd)
Funders
  • National Health and Medical Research Council
  • Australian Research Council
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Parasitic infections in humans and animals
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
  • Health Sciences › Veterinary › Small Animals › Helminth infection and control
Keywords
human toxocariasis, Toxocara canis, Toxocara cati, zoonotic parasitic disease, visceral larva migrans, ocular larva migrans, neurotoxocariasis, seroprevalence, albendazole, mebendazole, neglected tropical diseases, socio-economic impacts
MeSH terms
Adrenal Cortex Hormones, Anthelmintics, Drug Therapy, Combination, Humans, Mebendazole, Toxocariasis, Albendazole, Seroepidemiologic Studies, Neglected Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review